Stock To Buy News

Stock To Buy: Emkay Global Suggest This Auto Ancillaries Stock For 15% Upside In 12 Months

Stock To Buy: Emkay Global Suggest This Auto Ancillaries Stock For 15% Upside In 12 Months

Top 10 Infrastructure Stocks CMP Down More Than 40% From 52 Week High Levels

Top 10 Infrastructure Stocks CMP Down More Than 40% From 52 Week High Levels

5 Pharma Stocks Down More Than 70% From Their 52 Week High Levels

5 Pharma Stocks Down More Than 70% From Their 52 Week High Levels

ICICI Direct Bets On This Electrodes Stock For Aggressive 32% Upside, Revenue Up 23.6% YoY

ICICI Direct Bets On This Electrodes Stock For Aggressive 32% Upside, Revenue Up 23.6% YoY

Gained Decade High Market Share In FY22, Buy This Diversified FMCG Stock For 23% Gain: Motilal Oswal

Gained Decade High Market Share In FY22, Buy This Diversified FMCG Stock For 23% Gain: Motilal Oswal

BOB Capital Suggests Buy This NBFC Stock For 50% Potential Gains, Expect Earnings Of 32% CAGR

BOB Capital Suggests Buy This NBFC Stock For 50% Potential Gains, Expect Earnings Of 32% CAGR

Prabhudas Lilladhar Has Given Buy Call To This Navratna Stock For 18% Gains, Stock Near 52 Week High

Prabhudas Lilladhar Has Given Buy Call To This Navratna Stock For 18% Gains, Stock Near 52 Week High

Motilal Oswal Has A Buy Call On The Stock Of Mahindra Finance

Motilal Oswal Has A Buy Call On The Stock Of Mahindra Finance

Stock To Buy: This Large-Cap IT-Software Stock Can 17% Jump, Digital Segment Grew 38.8%

Stock To Buy: This Large-Cap IT-Software Stock Can 17% Jump, Digital Segment Grew 38.8%

Geojit Suggests Buy This Insurance Stock For 25% Gains, GPI Rose To Rs 1,442 Cr, Dividend Proposed

Geojit Suggests Buy This Insurance Stock For 25% Gains, GPI Rose To Rs 1,442 Cr, Dividend Proposed

Buy This Outperformer Mid Cap Stock For Strong 13% Gains, PAT Stood At Rs 806mn: Chola Wealth Direct

Buy This Outperformer Mid Cap Stock For Strong 13% Gains, PAT Stood At Rs 806mn: Chola Wealth Direct

Buy This Pharma Stock For 20% Returns, Reported Robust Revenue Of Rs 1,030 Crore: Geojit

Buy This Pharma Stock For 20% Returns, Reported Robust Revenue Of Rs 1,030 Crore: Geojit

FY23 Revenue Growth Is Expected At 15-20%, Buy This Small-Cap Construction Stock

FY23 Revenue Growth Is Expected At 15-20%, Buy This Small-Cap Construction Stock

Stocks To Buy: 6 Banking Stocks That Trade Way Below Long-Term Averages

Stocks To Buy: 6 Banking Stocks That Trade Way Below Long-Term Averages

Axis Securities Bets On This NBFC Stock For 18% Upside, Suggest Buy For Target Price Of Rs 2,195

Axis Securities Bets On This NBFC Stock For 18% Upside, Suggest Buy For Target Price Of Rs 2,195

Revenue Grew To Rs 163 Cr, Buy This Multi-Specialty Hospital Chain Stock For 40% Upside: ICICI Direct

Revenue Grew To Rs 163 Cr, Buy This Multi-Specialty Hospital Chain Stock For 40% Upside: ICICI Direct

ICICI Direct Has Given 'Buy' Call To This Liquor Stock For 23% Upside, Net Revenue Grew To Rs 813 Cr

ICICI Direct Has Given 'Buy' Call To This Liquor Stock For 23% Upside, Net Revenue Grew To Rs 813 Cr

Stock To Buy: Motilal Oswal Suggest This Insurance Stock For 20% Returns, Retail Health To Clock 20-25% CAGR

Stock To Buy: Motilal Oswal Suggest This Insurance Stock For 20% Returns, Retail Health To Clock 20-25% CAGR

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+